(AROC) AroCell - Performance 56.8% in 12m
Compare AROC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-49.29%
#31 in Group
Rel. Strength
91.37%
#694 in Universe
Total Return 12m
56.76%
#5 in Group
Total Return 5y
-65.78%
#32 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.82%
31th Percentile in Group
12m Total Return: AROC (56.8%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: AROC vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AROC
| Total Return (including Dividends) | AROC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 6.42% | -4.97% | -4.31% |
| 3 Months | 3.57% | -6.08% | -7.85% |
| 12 Months | 56.76% | 0.26% | 10.76% |
| 5 Years | -65.78% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | AROC | XLV | S&P 500 |
| 1 Month | 59.7% | -54.4% | -35.6% |
| 3 Months | -38.0% | -66.1% | -89.7% |
| 12 Months | 46.7% | -12% | 58.3% |
| 5 Years | -80.7% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #8 | 12.0% | 11.2% |
| 3 Month | #4 | 10.3% | 12.4% |
| 12 Month | #5 | 56.4% | 41.5% |
| 5 Years | #33 | -76.7% | -83.4% |
FAQs
Does AROC AroCell outperforms the market?
Yes,
over the last 12 months AROC made 56.76%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months AROC made 3.57%, while XLV made -6.08%.
Over the last 3 months AROC made 3.57%, while XLV made -6.08%.
Performance Comparison AROC vs Indeces and Sectors
AROC vs. Indices AROC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.17% | 10.7% | 20.3% | 46.0% |
| US NASDAQ 100 | QQQ | -10.1% | 10.7% | 20.3% | 44.8% |
| US Dow Jones Industrial 30 | DIA | -6.10% | 12.2% | 20.0% | 49.8% |
| German DAX 40 | DAX | -5.51% | 10.2% | 1.87% | 33.3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.64% | 9.92% | 21.7% | 48.1% |
| Hongkong Hang Seng | HSI | -5.90% | 9.30% | 18.4% | 42.7% |
| India NIFTY 50 | INDA | -0.74% | 4.86% | 18.7% | 55.0% |
| Brasil Bovespa | EWZ | -7.92% | 4.45% | 15.8% | 62.3% |
AROC vs. Sectors AROC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.03% | 12.0% | 11.6% | 34.4% |
| Consumer Discretionary | XLY | -10.5% | 10.5% | 17.1% | 42.4% |
| Consumer Staples | XLP | -0.71% | 3.67% | 15.0% | 47.3% |
| Energy | XLE | -4.82% | 18.1% | 22.7% | 68.7% |
| Financial | XLF | -6.21% | 11.2% | 12.2% | 37.5% |
| Health Care | XLV | -5.15% | 11.4% | 22.3% | 56.5% |
| Industrial | XLI | -6.34% | 10.5% | 20.0% | 49.9% |
| Materials | XLB | -4.92% | 10.9% | 27.2% | 62.1% |
| Real Estate | XLRE | -3.34% | 8.33% | 22.5% | 41.6% |
| Technology | XLK | -12.0% | 10.9% | 25.2% | 50.5% |
| Utilities | XLU | -4.02% | 4.74% | 17.2% | 36.3% |
| Aerospace & Defense | XAR | -7.73% | 6.72% | 9.03% | 29.8% |
| Biotech | XBI | -7.30% | 14.3% | 33.4% | 59.0% |
| Homebuilder | XHB | -6.42% | 12.4% | 35.3% | 64.7% |
| Retail | XRT | -5.38% | 9.35% | 24.4% | 60.4% |